LIM
ABBV icon

Letson Investment Management’s AbbVie ABBV Stock Holding History

Letson Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24.2M Buy
111,308
+15
+0% +$3.33K 9.3% 1
2025
Q4 		$25.4M Sell
111,293
-36
-0% -$8.2K 9.32% 1
2025
Q3 		$25.8M Buy
111,329
+324
+0.3% +$66K 9.25% 1
2025
Q2 		$20.6M Sell
111,005
-520
-0.5% -$96.6K 8.14% 1
2025
Q1 		$23.4M Sell
111,525
-29
-0% -$5.64K 9.42% 1
2024
Q4 		$19.8M Sell
111,554
-122
-0.1% -$22.4K 8.01% 1
2024
Q3 		$22.1M Buy
111,676
+205
+0.2% +$38.3K 8.66% 1
2024
Q2 		$19.1M Sell
111,471
-37
-0% -$6.13K 8.46% 1
2024
Q1 		$20.3M Buy
111,508
+1,635
+1% +$282K 8.59% 1
2023
Q4 		$17M Buy
+109,873
New +$16M 7.91% 1

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Letson Investment Management's ABBV Position: Q1 2026 in Review

Letson Investment Management increased its AbbVie (ABBV) stake by 0.01% in Q1 2026, buying an estimated $3.33K and bringing the position to 111,308 shares worth $24.2M. The position accounts for 9.3% of the portfolio, ranked #1.

Letson Investment Management first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $25.8M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Letson Investment Management held 111,308 shares of AbbVie worth $24.2M as of Q1 2026.
  • Letson Investment Management bought 15 AbbVie shares in Q1 2026, an estimated $3.33K.
  • AbbVie made up 9.3% of Letson Investment Management's portfolio in Q1 2026, its #1 holding.
  • Letson Investment Management first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • Letson Investment Management's AbbVie position peaked at $25.8M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Letson Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.